Literature DB >> 3260255

Synergistic and overlapping activities of tumor necrosis factor-alpha and IL-1.

K Last-Barney1, C A Homon, R B Faanes, V J Merluzzi.   

Abstract

TNF-alpha and IL-1 induce the production of PGE2 from human chondrosarcoma, fibrosarcoma, and carcinoma cell lines. When combined at sub-optimal concentrations, TNF-alpha and IL-1 synergistically stimulate PGE2 production. The synergy of TNF-alpha and IL-1 on the induction of PGE2 is partially neutralized by specific antibodies. In vitro, human rTNF-alpha is directly cytotoxic to several human transplantable tumor cell lines. These include a human carcinoma, human chondrosarcoma, and a human transformed fibroblast cell line. The cytotoxic effect of TNF-alpha was abrogated by a specific, neutralizing, polyclonal antibody. IL-1 had no direct cytotoxic effect on these cell lines; however, IL-1 enhanced the cytotoxic effects of TNF-alpha. The synergy of these two cytokines in the cytotoxic assay was neutralized by the addition of specific neutralizing antibodies.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3260255

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  25 in total

1.  Endogenous IL-1alpha from systemic sclerosis fibroblasts induces IL-6 and PDGF-A.

Authors:  Y Kawaguchi; M Hara; T M Wright
Journal:  J Clin Invest       Date:  1999-05       Impact factor: 14.808

2.  Fibroblast interleukin 1 beta: synergistic stimulation by recombinant interleukin 1 and tumor necrosis factor and posttranscriptional regulation.

Authors:  J A Elias; M M Reynolds; R M Kotloff; J A Kern
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

3.  Lack of effect of colony-stimulating factors, interleukins, interferons, and tumor necrosis factor on the growth and differentiation of cultured Reed-Sternberg cells. Comparison with effects of phorbol ester and retinoic acid.

Authors:  S M Hsu; P L Hsu
Journal:  Am J Pathol       Date:  1990-01       Impact factor: 4.307

4.  Modulation of secretory processes of phagocytes by IX 207-887.

Authors:  J Schnyder; P Cooper; A MacKenzie
Journal:  Springer Semin Immunopathol       Date:  1993

5.  Antimetastatic effect of endogenous tumor necrosis factor induced by the treatment of recombinant interferon gamma followed by an analogue (GLA-60) to synthetic lipid A subunit.

Authors:  I Saiki; H Maeda; J Murata; N Yamamoto; M Kiso; A Hasegawa; I Azuma
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

Review 6.  Inhibition of prostaglandin E2 formation and histamine action in cancer immunotherapy.

Authors:  P Uotila
Journal:  Cancer Immunol Immunother       Date:  1993-09       Impact factor: 6.968

7.  Roles of tumor necrosis factor and macrophages in lipopolysaccharide-induced accumulation of neutrophils in cutaneous air pouches.

Authors:  A G Harmsen; E A Havell
Journal:  Infect Immun       Date:  1990-02       Impact factor: 3.441

8.  Dysregulation of in vitro cytokine production by monocytes during sepsis.

Authors:  C Munoz; J Carlet; C Fitting; B Misset; J P Blériot; J M Cavaillon
Journal:  J Clin Invest       Date:  1991-11       Impact factor: 14.808

9.  IL-1 alpha gene expression and protein production by fibroblasts from patients with systemic sclerosis.

Authors:  Y Kawaguchi
Journal:  Clin Exp Immunol       Date:  1994-09       Impact factor: 4.330

10.  Differential modulation of cytokine production by macrolides: interleukin-6 production is increased by spiramycin and erythromycin.

Authors:  S Bailly; J J Pocidalo; M Fay; M A Gougerot-Pocidalo
Journal:  Antimicrob Agents Chemother       Date:  1991-10       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.